OSR Health Faces Potential Nasdaq Delisting Over Bid-Price Rule
OSR Health (NASDAQ: OSRH) has been notified by Nasdaq staff that its common stock and warrants may be delisted due to non-compliance with the minimum bid-price requirement. The company plans to appeal this decision through a hearing panel, emphasizing factors such as trading history, recent market activity, and strong business fundamentals in support of continued listing. The potential delisting could impact investor confidence and liquidity for OSR Health shares. If upheld, it may lead to reduced visibility on the Nasdaq exchange and complicate access for retail investors.
Topics: nasdaq_compliance stock_delisting